Listen Live
Donate
 on air
Schedule

KCRW

Read & Explore

  • News
  • Entertainment
  • Food
  • Culture
  • Events

Listen

  • Live Radio
  • Music
  • Podcasts
  • Full Schedule

Information

  • About
  • Careers
  • Help / FAQ
  • Newsletters
  • Contact

Support

  • Become a Member
  • Become a VIP
  • Ways to Give
  • Shop
  • Member Perks

Become a Member

Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

DonateGive Monthly

Copyright 2025 KCRW. All rights reserved.

Report a Bug|Privacy Policy|Terms of Service|
Cookie Policy
|FCC Public Files

Back to Press Play with Madeleine Brand

Press Play with Madeleine Brand

MDMA therapy for PTSD treatment? FDA panel says no

The panel was concerned about the strength of the evidence, allegations of participant abuse, and ill-defined therapeutic protocols. It’s a step backwards for the psychedelic movement.

  • rss
  • Share
By Madeleine Brand • Jun 11, 2024 • 1 min read

The panel was concerned about the strength of the evidence, allegations of participant abuse, and ill-defined therapeutic protocols. It’s a step backwards for the psychedelic movement.

  • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

    Madeleine Brand

    Host, 'Press Play'

  • KCRW placeholder

    Sarah Sweeney

    Vice President of Talk Programming, KCRW

  • KCRW placeholder

    Angie Perrin

    Producer, Press Play

  • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

    Amy Ta

    Digital News & Culture Editor

  • KCRW placeholder

    Josh Hardman

    editor and founder of Psychedelic Alpha

    NewsHealth & WellnessMental Health
Back to Press Play with Madeleine Brand